COMPARING ORAL PARACETAMOL DOSES IN PAEDIATRICS WITH THE NEW BNF-C DOSING

2016 ◽  
Vol 101 (9) ◽  
pp. e2.8-e2
Author(s):  
Nour Ajjan ◽  
Sian Shenton

The BNF-C 2014–20151 highlighted some key changes to the dosing of paracetamol in paediatrics, including a change in maximum daily dosage of oral paracetamol from 90 mg/kg/day to 75 mg/kg/day for post-operative pain, and inclusion of age-banded dosing for pain and pyrexia.The local Trust Paediatric Acute Pain Management Manual2 has acknowledged this change, but advised a maximum daily dose of 80 mg/kg/day. This audit was undertaken to determine whether national proposed changes were implemented in practice, in comparison with local guidelines.AimsThe aims and objectives of the audit were to compare oral paracetamol dosing in both medical and surgical settings with the new BNF-C dosing.MethodData were collected over a two week period in September 2014, from two medical and two surgical paediatric wards. The criteria for data collection included paediatric patients above the age of one month and up to 18 years, prescribed oral paracetamol for pain or pyrexia.The following data were collected:▸ Initials of patients and age (for identification purposes and to prevent duplications)▸ Weight (to assess appropriate and safe prescribing)▸ Reason for admission (to distinguish between medical and surgical settings).ResultsData were collected from 24 medical and 48 surgical patients (age range 1 month–16 years).The key findings were:19/24 medical patients were dosed according to the BNF-C age banded guidelines; 5/24 were dosed according to weight: 3 followed the Trust Manual; 1/24 followed the BNF-C, and 1 miscellaneous. No patients had a dose exceeding 80 mg/kg/day.87% of surgical patients were dosed according to the weight based calculation, 69% of whom were within the maximum daily dose of 75 mg/kg. Of the 31% whose daily dose exceeded 75 mg/kg, all were less than 80 mg/kg/day.The Trust Pain Manual does not include the dose banding as per the BNF-C but recommends 20 mg/kg 6 hourly (max 80 mg/kg/day) for acute pain in this age group.ConclusionChildren on the medical wards were prescribed paracetamol following age banded dosing as per BNF-C, whereas surgical wards were more likely to dose by weight following the Trust Pain Manual.The Trust Pain Manual differs from the BNF-C and recommends a maximum daily dose of 80 mg/kg/day for acute severe pain, to ensure adequate pain control and minimise calculation errors. Despite the new guidance in the BNF-C, it was found that many patients were prescribed a maximal daily dose greater than 75 mg/kg/day; however no patient's daily dose exceeded 80 mg/kg/day as indicated in the Manual.The main finding from the audit was that prescribers were not aware of the change in maximal daily dose of oral paracetamol. To highlight this important point, a poster was designed and distributed amongst the medical and surgical staff on the wards, highlighting that the dose should not exceed 75 mg/kg in a 24 hour period.

2021 ◽  
Vol 5 ◽  
pp. AB221-AB221
Author(s):  
Vianka Marcelino ◽  
Gráinne Marron ◽  
Sean Johnston ◽  
Dermot Hehir

2018 ◽  
Author(s):  
Nicole Brecher

Post-operative pain is accompanied with strong emotional and physical responses which may often discourage the healing process. Acute pain serves as a physical warning sign to the patient but when left unchecked, the acute pain process can increase nociceptor sensitivity and ultimately lead to chronic pain syndromes. Currently, it is thought that providing pain medication to block pain receptors prior to nociception might decrease the development of, or severity of, pain. Some practitioners have used ketamine as an adjunct pain medication perioperatively to decrease pain. The purpose of this review is to investigate the efficacy of Ketamine administered in a pre-hospital or pre-surgical setting on the overall pain management of surgical patients A literature search was performed on PubMed and Medline and using the PRISMA flowchart, and appropriate studies were identified. Each study was critically appraised and organized into tables to organize related variables and results. Variables included ketamine dosing, route of administration, the use of opioid or local anesthetic for comparison, type of surgery, and the length of duration into the post-operative period that pain scores were recorded. This systematic review supports that preemptive ketamine reduces acute pain in the immediate post-operative period.


2021 ◽  
Vol 12 ◽  
Author(s):  
Alfonso Ceccherini-Nelli ◽  
Elena Bucuci ◽  
Lisa Burback ◽  
Daniel Li ◽  
Maryam Alikouzehgaran ◽  
...  

Managing violent behavior is a particularly challenging aspect of hospital psychiatric care. Available pharmacological interventions are often unsatisfactory.Aim: To assess the effectiveness and safety of daytime zopiclone add-on administration in violent and difficult-to-treat psychiatric inpatients.Methods: Chart review of inpatients treated with daytime zopiclone, between 2014 and 2018, with up to 12 weeks follow-up. Effectiveness was retrospectively assessed with the Clinical Global Impression rating scale (CGI) and the frequency and severity of aggressive incidents recorded with the Staff Observation Aggression Scale-Revised (SOAS-R).Results: Forty-five (30 male, 15 female) cases, 18–69 years age range, average (SD) baseline CGI-S score of 5.4 (1.0), and a variety of diagnoses. Sixty-nine percent showed CGI-S improvement of any degree. For patients with at least one aggressive incident within 7 days prior to initiation of zopiclone (N = 22), average (SD) SOAS-R-Severity LOCF to baseline change was −3.5 (2.7) P < 0.0001. Most patients reported no side effects; 24% reported one or more side effects, and 11% discontinued zopiclone due to sedation (4), insomnia (1) or slurred speech (1). No SAEs were recorded. Zopiclone maximum daily dose correlated with CGI-S baseline-to-LOCF change (rho = −0.5, P = 0.0003). The ROC AUC of zopiclone maximum daily dose and improvement on CGI-S was 0.84 (95% CI 0.70–0.93, P < 0.0001). The ROC AUC of zopiclone maximum daily dose and SOAS-R-N improvement was 0.80 (95% CI 0.58–0.92; P = 0.0008) and maximum Youden's index value was achieved at a dose of >30 mg.Conclusions: Zopiclone doses >30 mg daily achieved the best anti-aggressive effect.


Author(s):  
Jeremy N. Cashman

Pain measurement is essential in evaluating response to analgesic therapy. The oral route is the route of choice for analgesics in non-fasting patients. Administering opioids by the neuraxial route provides superior analgesia to the same drug administered by parenteral routes. Clinical practice guidelines may be useful in acute pain management. Acute Pain Services improve the quality of post-operative pain management.


2020 ◽  
Vol 7 (4) ◽  
pp. 1
Author(s):  
Javad Yazdani ◽  
Farzin Ahmadpour

Introduction: Calcitonin is a polypeptide hormone regulating the metabolism calcium in the body. Many studies showed that calcitonin had analgesic effect on several painful circumstances. The aim of this study was to determine the effects of intranasal calcitonin during the immediate postoperative period on postoperative pain in patients undergoing maxillofacial fracture surgery. Materials and Methods: In this clinical trial which was conducted in April 2019 in Imam Reza Hospital of Tabriz, 16 patients with maxillofacial fracture were divided randomly into two groups. The intervention group was given 200UI of intranasal calcitonin and the control group received nasal spray of NaCl. The severity of pain was then evaluated daily for up to seven days after the operation, with the severity of: no pain (0) to the most severe pain (10) using visual analog scale for pain. The daily dose of analgesic was also measured. The patients were allowed to request 250 mg of injectable acetaminophen each day up to a maximum daily dose of 4 g (maximum permissible dose) in the event of pain. Results: The results show that the pain intensity between two groups was not significantly different. However in the seventh day the total acetaminophen consumption was significantly lower in the intervention group. Conclusion: calcitonin may be a useful medication to help to control the post operative pain by reducing the required dose of routine painkillers.


1975 ◽  
Author(s):  
C. Vasilescu ◽  
D. R. B. Jones ◽  
Anne Webber ◽  
R. G. Webber ◽  
N. C. Allan ◽  
...  

Serum F.D.P. values are elevated in venous thrombo-embolic disease. In order to define the place of daily serum F.D.P. estimation as a screening test 300 consecutive patients admitted to medical wards and 70 undergoing operation have been studied. All patients were screened for venous thrombosis (D.V.T.) with the 125I-fibrinogen test and if positive they were further investigated by lung scanning and phlebography. All had daily blood sampling for F.D.P. and fibrinogen. F.D.P. were estimated by the Staphylococcal Clumping test to provide rapid results, backed up by the Tanned Red Cell Haemag-glutination Inhibition Immunoassay (Wellcome). The mean F.D.P. in medical patients with no detectable thrombo-embolic disease was 10.5 ug/ml. In patients with positive leg scans the mean was 43.3 ug/ml. In surgical patients with negative leg scans the mean F.D.P. was 15.4 ug/ml and with positive leg scans 38.9 ug/ml. In those with positive lung scans it was 275 ug/ml.We conclude that a finding of elevated serum F.D.P. in hospital patients strongly favours the diagnosis of venous thrombo-embolic disease. Low F.D.P. values do not exclude the condition.


Author(s):  
Alaa Ali M. Elzohry MD ◽  
Ali M. El Foli

Acute pain is an important fear for most patients and influences their recovery and overall experience. Poorly treated, it could lead to undesirable effects and patient dissatisfaction. Hence, it is important to understand, assess and treat acute pain effectively. Pain management has been transferred from intraoperative into per operative period throughout the emergence of modern anesthesiology. Pain management in postoperative period is one of the most essential components of sufficient post-surgical patients care. The objective of this review is to define and demonstrate the risks and different sequelae of acute post operative pain.


AORN Journal ◽  
2003 ◽  
Vol 77 (2) ◽  
pp. 374-395 ◽  
Author(s):  
Gwen D. Sherwood ◽  
Jeanette A. McNeill ◽  
Patricia L. Starck ◽  
Geri Disnard

Sign in / Sign up

Export Citation Format

Share Document